• Two Medical Centers Adopt ZappRx’s Digital Platform to Ease Prescription of Specialty Medications
  • Esbriet, Ofev Safety Profiles in Routine Practice Similar to Clinical Trial Reports, Study Finds
  • How Relationships Can Change with a Diagnosis of IPF
  • Samumed’s Candidate PF Therapy, SM04646, Found to Be Well-tolerated and Safe in Phase 1 Trial
  • Some Tips and Resources to Help Tackle Your Sleep Problems
  • Social Media and My IPF Story: A Public to Private Journey
  • Esbriet, Ofev Remain Only Effective IPF Therapies Though PRM-151 is Gaining Ground, Comparison Study Finds
  • Northwestern Researchers Find New Link Between Immune Cells and Pulmonary Fibrosis
  • What Do You Say? Responding to Awkward Statements and Stares
  • Researchers Start a Study of Lung Fibrosis in Patients With Hermansky-Pudlak Syndrome
  • Patient Community Urges Writing to Representatives for Help
  • The Balancing Act of Living with IPF